Skip to content
NP

Updated:

Nivagen Pharmaceuticals

Nivagen Pharmaceuticals is a Sacramento-based company founded in 2009. It develops, acquires, and sells generic prescription and over-the-counter products...

Overview

Nivagen Pharmaceuticals is a Sacramento-based company founded in 2009. It develops, acquires, and sells generic prescription and over-the-counter products for the North American market. The company has secured $26 million in total funding.

General information

Firm type

Specialty Pharmaceuticals (Generics and Sterile Injectables)

Year founded

2009

Location

Region

North America

Country

United States

City

Sacramento

Corporate office

Sacramento, CA, United States

Sector focus

PharmaceuticalsHealthcare Services

Frequently asked questions

Who owns Nivagen Pharmaceuticals?

Ownership of Nivagen Pharmaceuticals is not publicly disclosed. The firm is privately held, based in Sacramento, California. No principals or institutional backers are named in available records.

What type of pharmaceutical products does Nivagen focus on?

Nivagen Pharmaceuticals is described as a company in the generic and specialty pharmaceutical space. Specific product pipelines, therapeutic areas, or approved drugs are not publicly documented.

Where is Nivagen Pharmaceuticals headquartered?

The firm is headquartered in Sacramento, California, United States. No additional offices or international presence are indicated in public sources.

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Need institutional-grade insight on investors?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Explore more profiles